Lidoderm and Infusion site swelling - a phase IV clinical study of FDA data

Summary:

Infusion site swelling is reported as a side effect among people who take Lidoderm (lidocaine), especially for people who are female, 60+ old, also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site swelling when taking Lidoderm. It is created by eHealthMe based on reports of 10,321 people who have side effects when taking Lidoderm from the FDA, and is updated regularly.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

What is Infusion site swelling?

Infusion site swelling is found to be associated with 581 drugs and 360 conditions by eHealthMe. Check the latest studies of Infusion site swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

10,321 people reported to have side effects when taking Lidoderm.
Among them, 16 people (0.16%) have Infusion site swelling.

Could Lidoderm cause Infusion site swelling?

Among these 16 people:

What is the gender of people who have Infusion site swelling when taking Lidoderm? *

female: 100 %
male: 0.0 %

What is the age of people who have Infusion site swelling when taking Lidoderm? *

What are other drugs people take besides Lidoderm? *

What are other side effects people have besides Infusion site swelling? *

Sinusitis (inflammation of sinus): 9 people, 56.25%
Joint Pain: 6 people, 37.50%
Fall: 6 people, 37.50%
Urinary Tract Infection: 6 people, 37.50%
Infusion Site Erythema (reddening of the skin at infusion site): 6 people, 37.50%
Head Injury: 6 people, 37.50%
Blood Potassium Abnormal: 6 people, 37.50%
Renal Cyst (kidney cyst): 5 people, 31.25%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 5 people, 31.25%
Joint Injury: 5 people, 31.25%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 12 people, 75.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.25%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.25%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lidoderm and have Infusion site swelling?

- Check whether Infusion site swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lidoderm:

Lidoderm (10,524 reports)

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site swelling:

Infusion site swelling (582 drugs)

Browse all the conditions that are associated with Infusion site swelling:

Infusion site swelling (360 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine (the active ingredients of Lidoderm) and Lidoderm (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.